Artrya Limited (ASX: AYA)
Sector: Health Care
Market cap: A$453M (as of 2 Nov 2026)
Artrya Limited is a medical technology company developing software which automates the analysis of heart computed tomography (CT) scans to assist in the diagnosis of Coronary Artery Disease.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 30 Sept 2026 | SEE ANNEXURE 1 | Increase | 6.9679% → 8.0213% | Filing ↗ |
| 24 Sept 2026 | Vanguard Group (The Vanguard Group, Inc. and its controlled entities including Vanguard Investments Australia Ltd. and those listed in Annexure A) | Entry | ?% → 5.011% | Filing ↗ |
| 22 Sept 2026 | SEE ANNEXURE 1 | Increase | 5.001% → 6.9679% | Filing ↗ |
| 10 Sept 2026 | REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATES | Decrease | 11.06% → 9.97% | Filing ↗ |
| 3 Aug 2026 | UBS Group AG and its related bodies corporate | Exit | — | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about AYA in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has AYA raised money in the last year, and at what discount?
- What was AYA's latest cash position and runway?
Loading AYA…